Genmab Share Slump Is Buying Opportunity, Nordea Says

(PLX AI) – Genmab's recent share slump is a buying opportunity, analysts at Nordea said, maintaining an unchanged price target of DKK 3,191.Investors should add to positions ahead of the J&J Pharma Business Review day on Nov. 18, Nordea saidGenmab …